Haemonetics (HAE) Sparks Confidence Following Vivasure Acquisition [Yahoo! Finance]
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Yahoo! Finance
On January 12, Michael Petusky from Barrington maintained his Outperform rating on Haemonetics Corporation (NYSE:HAE). He also revised his estimated price target upward from $90 to $93, implying an upside of almost 41%. oatautta/Shutterstock.com Petusky's rating and target price adjustment came at the back of the company's recent acquisition of Vivasure Medical, an Ireland-based advanced polymer implants and delivery systems manufacturer. The analyst sees this deal in a favorable light, which makes him optimistic about the stock performance. Earlier, on December 17, Mizuho Securities analyst Anthony Petrone had also reaffirmed his Outperform rating on Haemonetics Corporation (NYSE:HAE), while increasing the price target from $75 to $90. His revisions now lead to an upside potential of over 36% from the current level. Petrone's revisions were part of Mizuho Securities' adjustments across the medical devices and diagnostics space, in line with its 2026 outlook. The analyst note
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Haemonetics (NYSE:HAE) was given a new $94.00 price target on by analysts at Barrington Research.MarketBeat
- Haemonetics (NYSE:HAE) was given a new $80.00 price target on by analysts at Mizuho.MarketBeat
- Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.MarketBeat
- Haemonetics (NYSE:HAE) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- Haemonetics GAAP EPS of $0.95 misses by $0.01, revenue of $338.9M beats by $6.18M [Seeking Alpha]Seeking Alpha
HAE
Earnings
- 2/5/26 - Beat
HAE
Sec Filings
- 2/5/26 - Form 8-K
- 2/5/26 - Form 10-Q
- 1/9/26 - Form 8-K
- HAE's page on the SEC website